Regulation, Innovation, and Access: Understanding the Evolving Landscape of Peptides
About this episode
Regan Archibald discusses the impact of regulatory changes on peptides and their implications for healthcare.
In this session, Regan Archibald explores recent regulatory changes affecting peptides and what they could mean for clinicians, patients, and compounding pharmacies. He outlines how shifting FDA classifications may influence access to certain compounds while highlighting the broader tension between innovation, safety oversight, and pharmaceutical economics. The discussion also provides an overview of several commonly discussed peptides, explaining their origins as naturally occurring or derived molecules and their growing interest within personalized approaches to health. Throughout, Archibald emphasizes the importance of quality sourcing, regulatory awareness, and individualized strategies, framing the current moment as part of a larger transformation in how emerging therapies are evaluated, accessed, and integrated into modern healthcare. RESOURCES: Book Comprehensive Labs: https://agelessfuture.com/longevity-labs/ FREE copy of The Peptide Blueprint: https://agelessfuture.com/blueprint Sign up for future Health Accelerator Challenges calls LIVE! https://us02web.zoom.us/webinar/register/WN_YZsiUMOzSyqcE8IinC5YEQ#/registration Books…
More episodes of Ageless Future
Explore listener stats, chart rankings, contacts and more on the Ageless Future podcast page.